Experimental drug shows promise in clearing HIV from brain
An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new Tulane University study.
17 hours ago
0
29
An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new Tulane University study.
17 hours ago
0
29
Three people effectively cured of HIV have spoken about how a risky transplant procedure saved their lives, with one saying they are "living proof" of hope in the fight against the virus.
Jul 25, 2024
0
2
Researchers in George Mason University's Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center have conducted a breakthrough proof-of-concept study, published in the journal Gene Therapy, ...
Jul 24, 2024
0
19
Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa. These young people are much more likely to experience treatment failure than adults. Experts long assumed ...
Jul 17, 2024
0
0
Now that more people with HIV in South Africa are on antiretroviral therapy (medicines to treat HIV), more are surviving long enough to face the health consequences of tobacco smoking.
Jul 16, 2024
0
0
A multinational team led by Weill Cornell Medicine investigators developed a test that will help measure the persistence of HIV in people affected by viral strains found predominantly in Africa—a vital tool in the search ...
Jul 2, 2024
0
55
People with HIV can breastfeed their babies, as long as they are taking medications that effectively suppress the virus that causes AIDS, a top U.S. pediatricians' group said Monday in a sharp policy change.
May 20, 2024
0
0
When a person is diagnosed with HIV, they are placed on a lifelong HIV treatment regimen, called antiretroviral therapy, to keep the virus under control. But for many people, having to take medicine every day can be a struggle ...
May 14, 2024
0
0
Researchers from the University of Illinois have demonstrated the importance of cell-type-specific targeting in the treatment of HIV. Their study, published in the Proceedings of the National Academy of Sciences, is one of ...
May 13, 2024
0
9
For people with HIV (PWH), semaglutide is effective for metabolic dysfunction-associated steatotic liver disease (MASLD), according to a research letter published online April 30 in the Annals of Internal Medicine.
Apr 30, 2024
0
0